Login / Signup

Effect of peramivir on respiratory symptom improvement in patients with influenza virus infection and pre-existing chronic respiratory disease: Findings of a randomized, open-label study.

Motokazu KatoYutaka SaishoHiroshi TanakaTakuma Bando
Published in: Influenza and other respiratory viruses (2020)
In patients with chronic respiratory diseases, peramivir-single was not significantly different from peramivir-repeat and was more effective than oseltamivir at alleviating respiratory symptoms.
Keyphrases
  • open label
  • respiratory tract
  • clinical trial
  • randomized controlled trial
  • phase ii
  • physical activity